Representational photo: Barack Obama, George Bush, Bill Clinton

Photo: Interview Times

Obama, Bush, Clinton Ready To Vaccinate Publicly To Raise Awareness

To convince the people of COVID-19 vaccine's effectiveness, three former US Presidents - Barack Obama, George Bush and Bill Clinton - have decided to vaccinate in public. However, the trio expects US' top epidemiologist Dr Anthony Fauci's confirmation on the safety of a vaccine before inoculation. Reportedly, the US Food and Drug Administration will take a call on the vaccines in their meetings on December 10 and 17.

Fri, 04 Dec 2020 - 12:16 PM / by Harsh Vardhan

Tags: U.SA., President, food and drug administration, vaccine, Covid-19, Pfizer, Moderna

Courtesy: Hindustan Times

Sun Pharma

Photo: The Economic Times

Sun Pharma's Diabetes Drug Likely to 'Cause Cancer'; Company Recalls 747 Bottles

According to the US Food and Drug Administration (FDA) report, Mumbai-based Pharmaceutical Company, Sun Pharma has recalled 747 bottles of RIOMET ER from the American market. Reportedly, the drug was used for the treatment of diabetes and the FDA has ascertained an increased presence of N-nitrosodimethylamine (NDMA) in the drug. N-nitrosodimethylamine is believed to cause cancer, if used in high amounts. FDA has stated that the recall process… read-more

Sun, 11 Oct 2020 - 02:11 PM / by Sneha Ramesh

Tags: sun pharma, food and drug administration, US, Diabetes

Courtesy: The Economic Times


Photo: BioSpectrum India

Glenmark Pharmaceuticals Receives Approval For Multiple Sclerosis Drug

Glenmark Pharmaceuticals Inc., USA has informed that it has received the regulatory approvals for Dimethyl Fumarate delayed-release capsules by the US Food and Drug Administration (FDA). The capsules which have got approval for 120mg and 240mg, can be used for the treatment of relapsing forms of multiple sclerosis. Multiple sclerosis is a chronic illness of central nervous system that affects the brain, spinal cord, and optic nerves.

Wed, 07 Oct 2020 - 12:39 PM / by Sneha Ramesh

Tags: food and drug administration, sclerosis, drug, glenmark pharmaceuticals

Courtesy: The Economic Times

Lupin Drugs

Photo: Microbioz India

Mumbai-based Pharma Launches Generic Breast Cancer Drug In US

Lupin, a Mumbai-based pharmaceutical company, on September 30 announced that it has launched '250mg Lapatinib' tablets in the US. The company stated that the Lapatinib tablets are used for the treatment of patients with 'advanced or metastatic breast cancer', and can also be used for treatment of 'postmenopausal women with positive metastatic breast cancer'. Reportedly, the company's… read-more

Thu, 01 Oct 2020 - 09:18 AM / by Sneha Ramesh

Tags: Breast cancer, Lupin Pharma, United States, food and drug administration

Courtesy: The Economic Times


Photo: PVRI

USFDA Approves 'Treprostinil' Injection to Treat Pulmonary Arterial Hypertension

US Food and Drug Administration (USFDA) has given preliminary approval for the Treprostinil injection, which aims to treat pulmonary arterial hypertension. The drug is produced by the subsidiary of Alembic Pharmaceuticals and is expected to be equivalent to Remodulin Injection. Patients with pulmonary arterial hypertension experience high blood pressure in arteries that go from the heart to the lungs.

Tue, 08 Sep 2020 - 09:28 AM / by Sneha Ramesh

Tags: health care, food and drug administration, Pharmacy, United States

Courtesy: The Economic Times

Lung cancer

Photo: Outlook India

US FDA Approves Oral Drug 'Gavreto' to Treat Lung Cancers

The lung cancer drug, Gavreto, on September 5 has passed the approval standards of the US Food and Drug Administration (USFDA). The drug, developed by Roche Holding AG in collaboration with Blueprint Medicines Corp, is intended to treat patients with Non-Small Cell Lung Cancer (NSCLC). Gavreto is an oral RET-targeted therapy. Reportedly, it is designed to selectively inhibit RET alterations… read-more

Mon, 07 Sep 2020 - 08:40 AM / by Sneha Ramesh

Tags: health care, Lung Cancer, Pharmacy, food and drug administration

Courtesy: The Economic Times


Photo: Mylan Laboratories

Mylan Drug Plant at Telangana Not Maintaining Standards: US FDA

The Mylan Laboratories Ltd's Unit 7 is deviating from the Current Good Manufacturing Practices(CGMP), warned the US Food and Drug Administration (FDA). The FDA, in its letter to Mylan, said that the company had not followed adequate cleaning measures and testing of raw materials for impurities; this could contaminate the materials that are used to produce medicines. The plant is located in the Sangareddy district of Telangana.

Sun, 06 Sep 2020 - 08:19 AM / by Sneha Ramesh

Tags: Telangana, Pharmacy, United States, food and drug administration

Courtesy: The Economic Times